Calendar

ASM Microbe 2018

Click to view our ASM presentations.

Stocks

Share Price

LSE: SUMM
34.50p -1.50
at 04:22pm GMT 19 Jul 2018

NASDAQ: SMMT
$2.27 0.10
at 03:59pm ET 19 Jul 2018

Current Programmes

  • C. difficile Infection

    Clostridium difficile infection (‘CDI’) is a major healthcare issue in hospitals, long-term care homes, and increasingly in the wider community. It is a serious illness caused by infection of the colon by the bacteria, C. difficile, which produces toxins that cause inflammation, severe diarrhoea and can in the most serious of cases be fatal.

    Read More
  • C. Difficile Infections banner image

    Gonorrhoea

    Gonorrhoea has been identified as one of three urgent threats by the US Centers for Disease Control and Prevention and a high priority pathogen by the World Health Organisation.

    We are developing new mechanism antibiotics for the treatment of all gonorrhoea.

    Read More
  • Discuva Platform

    The world is entering an era of untreatable infections. Without urgent action, once easily curable infections could become global health crises.

    Summit's approach to tackling this problem is the development of new mechanism antibiotics and is using its proprietary Discuva Platform as part of its research activities.

    Read More